Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Composition: ComparativeEvidenceSynthesisReport: GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk

Page standards status: Informative

version: 90; Last updated: 2025-03-25 23:23:30+0000

Profile: ComparativeEvidenceSynthesisReport

Artifact Description:

Example of ComparativeEvidenceSynthesisReport Profile

ArtifactPublicationStatus: Active

url: https://fevir.net/resources/Composition/236538

identifier: FEvIR Object Identifier/236538, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-comparative-evidence-report-85390-85789

status: Final

type: Comparative Evidence Synthesis Report

date: 2025-03-25 23:23:30+0000

author: Qiukui Hao

title: ComparativeEvidenceSynthesisReport: GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk

custodian: Computable Publishing LLC

relatesTo

type: Part Of

target: MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)

relatesTo

type: Cite As

target:

ComparativeEvidenceSynthesisReport: GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk [Database Entry: FHIR Composition Resource]. Contributors: Qiukui Hao [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236538. Revised 2025-03-20. Available at: https://fevir.net/resources/Composition/236538. Computable resource at: https://fevir.net/resources/Composition/236538.